Cargando…
Comprehensive genetic diagnosis of acute myeloid leukemia by next-generation sequencing
Differential induction therapy of all subtypes of acute myeloid leukemia other than acute promyelocytic leukemia is impeded by the long time required to complete complex and diverse cytogenetic and molecular genetic analyses for risk stratification or targeted treatment decisions. Here, we describe...
Autores principales: | Mack, Elisabeth K.M., Marquardt, André, Langer, Danny, Ross, Petra, Ultsch, Alfred, Kiehl, Michael G., Mack, Hildegard I.D., Haferlach, Torsten, Neubauer, Andreas, Brendel, Cornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355503/ https://www.ncbi.nlm.nih.gov/pubmed/30190345 http://dx.doi.org/10.3324/haematol.2018.194258 |
Ejemplares similares
-
A Bioinformatics View on Acute Myeloid Leukemia Surface Molecules by Combined Bayesian and ABC Analysis
por: Thrun, Michael C., et al.
Publicado: (2022) -
Advancing leukemia diagnostics: Role of Next Generation Sequencing (NGS) in acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2020) -
Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019) -
Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia
por: Hoffmann, Joerg, et al.
Publicado: (2023) -
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia
por: Hoffmann, Joerg, et al.
Publicado: (2022)